share_log

Cellebrite DI (NASDAQ:CLBT) Reaches New 12-Month Low at $4.10

Cellebrite DI (NASDAQ:CLBT) Reaches New 12-Month Low at $4.10

凱萊布里特DI(納斯達克：CLBT)跌至4.10美元，創12個月新低
Financial News Live ·  2022/09/22 18:52

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) shares hit a new 52-week low on Thursday . The stock traded as low as $4.10 and last traded at $4.14, with a volume of 24199 shares changing hands. The stock had previously closed at $4.28.

凱樂布萊特DI有限公司(納斯達克代碼：CLBT-GET Rating)的股價週四創下52周新低。該股一度跌至4.1美元，最新報4.14美元，成交量為24199股。該股此前收盤價為4.28美元。

Analysts Set New Price Targets

分析師設定新的價格目標

CLBT has been the subject of a number of research analyst reports. Needham & Company LLC lifted their target price on shares of Cellebrite DI from $6.00 to $6.50 and gave the stock a "buy" rating in a research report on Thursday, August 11th. William Blair downgraded shares of Cellebrite DI from an "outperform" rating to a "market perform" rating in a research report on Friday, August 12th. Bank of America downgraded shares of Cellebrite DI from a "buy" rating to a "neutral" rating and cut their target price for the stock from $6.50 to $6.00 in a research report on Friday, August 12th. Cowen cut their target price on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, August 12th. Finally, Cowen cut their target price on shares of Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research report on Friday, August 12th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $9.71.

CLBT已成為多份研究分析師報告的主題。Needham&Company LLC在8月11日(星期四)的一份研究報告中將Cellebrite DI的目標價從6.00美元上調至6.50美元，並給予該股“買入”評級。在8月12日星期五的一份研究報告中，威廉·布萊爾將Cellebrite DI的股票評級從“跑贏大盤”下調至“市場表現”。在8月12日週五的一份研究報告中，美國銀行將Cellebrite DI的股票評級從買入下調至中性，並將該股的目標價從6.50美元下調至6.00美元。考恩在8月12日(星期五)的一份研究報告中將Cellebrite DI的目標價從13.00美元下調至10.00美元，併為該公司設定了“跑贏大盤”的評級。最後，考恩將Cellebrite DI的目標價從13.00美元下調至10.00美元，並在8月12日(星期五)的一份研究報告中為該公司設定了“跑贏大盤”的評級。兩名研究分析師對該股的評級為持有，六名分析師對該公司的評級為買入。根據MarketBeat的數據，該公司的普遍評級為“適度買入”，平均目標價為9.71美元。

Get
到達
Cellebrite DI
絲光沸石DI
alerts:
警報：

Cellebrite DI Trading Down 3.5 %

Cellebrite DI降價3.5%

The company has a market cap of $778.67 million, a PE ratio of 5.78, a PEG ratio of 9.96 and a beta of 0.87. The business's 50 day moving average is $5.04 and its two-hundred day moving average is $5.36.

該公司市值為7.7867億美元，市盈率為5.78倍，聚乙二醇率為9.96倍，貝塔係數為0.87。該業務的50日移動均線切入位在5.04美元，200日移動均線切入位在5.36美元。

Institutional Trading of Cellebrite DI

凱勒布利特DI的機構交易

Several hedge funds have recently bought and sold shares of the stock. Phoenix Holdings Ltd. raised its position in shares of Cellebrite DI by 303.6% during the 1st quarter. Phoenix Holdings Ltd. now owns 2,296,345 shares of the company's stock valued at $14,706,000 after buying an additional 1,727,379 shares in the last quarter. Greenhaven Road Investment Management L.P. purchased a new stake in shares of Cellebrite DI during the 4th quarter valued at about $9,453,000. Blair William & Co. IL raised its position in shares of Cellebrite DI by 3,021.1% during the 1st quarter. Blair William & Co. IL now owns 523,978 shares of the company's stock valued at $3,353,000 after buying an additional 507,190 shares in the last quarter. ARK Investment Management LLC purchased a new stake in shares of Cellebrite DI during the 1st quarter valued at about $2,621,000. Finally, CIBC Asset Management Inc raised its position in shares of Cellebrite DI by 5.8% during the 1st quarter. CIBC Asset Management Inc now owns 2,352,733 shares of the company's stock valued at $15,057,000 after buying an additional 129,244 shares in the last quarter. Hedge funds and other institutional investors own 20.41% of the company's stock.
幾家對衝基金最近買賣了該股的股票。菲尼克斯控股有限公司在第一季度將其在Cellebrite DI的股票頭寸提高了303.6%。鳳凰衞視控股有限公司目前持有該公司2,296,345股股票，價值14,706,000美元，該公司在上個季度又購買了1,727,379股。Greenaven Road Investment Management L.P.在第四季度購買了Cellebrite DI的新股，價值約9,453,000美元。Blair William&Co.IL在第一季度將其在Cellebrite DI的股票頭寸增加了3021.1%。Blair William&Co.IL現在持有523,978股該公司股票，價值3,353,000美元，上個季度又購買了507,190股。方舟投資管理有限責任公司在第一季度購買了Cellebrite DI的新股份，價值約2,621,000美元。最後，加拿大帝國商業銀行資產管理公司在第一季度將其在Cellebrite DI的股票頭寸提高了5.8%。加拿大帝國商業銀行資產管理公司(CIBC Asset Management Inc.)目前持有該公司2,352,733股股票，價值15,057,000美元，上一季度又購買了129,244股。對衝基金和其他機構投資者持有該公司20.41%的股份。

About Cellebrite DI

關於Cellebrite DI

(Get Rating)

(獲取評級)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.

Cellebrite DI Ltd.為法律批准的調查開發解決方案。其DI平臺允許用户在整個調查生命週期中收集、審查、分析和管理與法律批准的調查有關的數字數據，並在各種案件中使用解決方案，包括剝削兒童、兇殺、反恐、邊境控制、性犯罪、人口販運、企業安全、知識產權盜竊和民事訴訟。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
  • The Institutions Hold On To Darden Restaurants International
  • What Steelcase's Earnings Say About the Return to the Office?
  • Is The Golden Age Of Homebuilding Already Over?
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit
  • 免費獲取StockNews.com關於Cellebrite DI(CLBT)的研究報告
  • 這些機構持有達頓餐飲國際公司的股份
  • 斯蒂爾凱斯的收益説明瞭他重返辦公室的原因嗎？
  • 住房建設的黃金時代已經結束了嗎？
  • 這三大股利支付者也擁有強勁的價格增長
  • 天然氣價格繼續回升，這些股票應該會受益

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.

接受《凱爾布賴特DI日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cellebrite DI和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論